Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNaked Wine Regulatory News (WINE)

Share Price Information for Naked Wine (WINE)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
70.20
Ask:
70.60
Spread: 0.40 (0.57%)
Market Cap: £46.29m
WINE Live PriceLast checked at - London Stock Exchange

Intraday Naked Wine Share Chart

Directorate Change

13 Jun 2019 07:00

RNS Number : 0357C
Majestic Wine PLC
13 June 2019
 

Majestic Wine PLC

Directorate Changes

13 June 2019

 

Majestic Wine PLC announces that, due to an increase in other professional commitments, Greg Hodder will step down as Chairman at the conclusion of the AGM in August and will retire from the Board six months later after a period of transition.

 

The Board is pleased to announce the appointment of John C. Walden as Non-Executive Director and Chairman Designate. John has been at the forefront of multi-channel, consumer-driven retailing for more than 20 years, with a proven record of growth across a diverse range of organisations, from start-ups to listed companies. He has been successful in creating transformational results through strategic insight, engaging leadership and ability to combine entrepreneurialism with scale. John has specific expertise in digital and multi-channel consumer businesses and in leading reinvigoration, turnaround and organizational change in established enterprises across the US and UK markets.

 

The Board is also pleased to announce the appointment of Nicholas Devlin to the Board as an Executive Director in the new position of Group Chief Operating Officer. Nick has been, and will remain, the President of our US Naked Wines division and is based in California. Nick has played a significant role in the development of our current business worldwide and has a wealth of experience in corporate strategy, specifically in analytical problem solving and customer segmentation.

 

Both appointments will take effect from today.

 

Ian Harding, Senior Independent Director, commented:

 

"I am delighted to welcome John to our Board as Chairman Designate. Following an extensive external selection process, it was evident that John was uniquely qualified to become our next Chairman. His experience of UK plc corporate governance, digital and multi-channel consumer businesses and US markets will be an invaluable asset to the Board as we enter our new growth phase.

 

"I am also delighted to welcome Nick to the Board. The Group has ambitious growth plans and now is the time to strengthen the leadership team with this newly created COO role to help successfully deliver our full potential. It is a testament to the quality and depth of the people in our business that we have been able to make this an internal appointment.

 

"Lastly, on behalf of the Board, I would like to thank Greg for his dedication, guidance and oversight of the Group's transition. He will be missed and I thank him for agreeing to stay an extra six months to ensure a smooth transition at this important time for the business."

 

John C. Walden, Chairman Designate, commented:

 

"I am delighted to be joining the team at this pivotal time and am looking forward to the opportunity to work together with them to deliver on the new strategy in a way that will benefit all concerned."

 

 

John Carl Walden (59) holds or has held the following directorships in the past five years:

 

Current Directorships or Partnerships

Previous Directorships or Partnerships

Inversion INC. LLC

L1R HB Holdings Limited

 

Holland & Barrett International LTD

 

FTD Companies INC

 

Home Retail Group Limited

 

Home Retail Group (UK) Limited

 

Argos Limited

 

HHGL Limited

 

Homebase Group Limited

 

Hampden Group Limited

 

John joined FTD Companies INC ("FTD") for a period from March 2017 to July 2018, the purpose of which was to assist FTD with a turnaround plan. On 3 June 2019, FTD announced that it and substantially all of its domestic subsidiaries had filed voluntary petitions commencing cases under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware to facilitate the completion of strategic initiatives resulting from the FTD's previously announced strategic review.

 

Mr. Walden holds no shares in the Group.

 

Nicholas James Devlin (34) holds or has held the following directorships in the past five years:

 

 Current Directorships or Partnerships

Previous Directorships or Partnerships

www.nakedwines.com Inc.

Nil

 

Mr. Devlin holds 15,349 shares in the Group in his personal capacity and 4,532 shares through a related person (his spouse). There are no other matters which are required to be disclosed in accordance with Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

For further information, please contact:

 

Majestic Wine PLC

Rowan Gormley, Chief Executive Officer

James Crawford, Chief Financial Officer

 

Tel: 01923 298 200

Investor.relations@majestic.co.uk

 

 

 

Investec (NOMAD & Broker)

David Flin / Carlton Nelson / David Anderson

 

 

Tel: 0207 597 5970

Instinctif Partners (PR Agency)

Damian Reece

Tel: 0207 457 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKLLFFKQFEBBL
Date   Source Headline
29th Jul 20257:00 amRNSNotice of Full Year Results
22nd Jul 20257:00 amRNSAppointment of Non-Executive Chair
18th Jun 20254:30 pmRNSDirector/PDMR Shareholding
11th Jun 202510:00 amRNSDirector/PDMR Shareholding
9th Jun 202511:55 amRNSDirector/PDMR Shareholding
20th May 20251:20 pmRNSDirector/PDMR Shareholding
19th May 20252:05 pmRNSHolding(s) in Company
12th May 202512:10 pmRNSDirector/PDMR Shareholding
29th Apr 202510:10 amRNSDirector/PDMR Shareholding
25th Apr 20257:00 amRNSPre-Close Trading Update
16th Apr 20255:10 pmRNSHolding(s) in Company
4th Apr 202512:40 pmRNSHolding(s) in Company
3rd Apr 20257:00 amRNSHolding(s) in Company
31st Mar 20258:33 amRNSHolding(s) in Company
31st Mar 20257:00 amRNSDirectorate Change
28th Mar 202512:30 pmRNS-RStrategy Event Materials
27th Mar 20257:00 amRNSNew Strategic Plan
7th Mar 20257:00 amRNSAppointment of Joint Broker
4th Mar 202510:10 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSStrategy Event and IMC Presentation
29th Jan 20257:00 amRNSPeak Season Trading Update
27th Jan 202511:50 amRNSHolding(s) in Company
7th Jan 20259:15 amRNSHolding(s) in Company
31st Dec 20248:15 amRNSHolding(s) in Company
10th Dec 20247:00 amRNSHalf-year Report
5th Dec 20242:45 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSConfirmation of Half Year Results Release Date
6th Nov 20247:00 amRNSBlock Listing Six Monthly Return
11th Oct 20248:30 amRNSDirector/PDMR Shareholding
30th Sep 20245:24 pmRNSResult of AGM
30th Sep 20245:23 pmRNSDirectorate Change
5th Sep 20242:10 pmRNSDirector/PDMR Shareholding
4th Sep 20244:25 pmRNSDirector/PDMR Shareholding
4th Sep 20244:15 pmRNSHolding(s) in Company
4th Sep 20247:00 amRNSAGM and Annual Report and Accounts
28th Aug 20247:01 amRNSAppointment of Chief Financial Officer
28th Aug 20247:00 amRNSFinal Results
23rd Aug 20247:00 amRNSConfirmation of Full Year Results Release Date
13th Aug 202410:10 amRNSHolding(s) in Company
18th Jul 202410:45 amRNSHolding(s) in Company
16th Jul 20243:39 pmRNSHolding(s) in Company
9th Jul 20247:01 amRNSCFO Succession Plan
9th Jul 20247:00 amRNSCompletion of new $60m credit facility
24th May 20245:45 pmRNSHolding(s) in Company
22nd May 20241:15 pmRNSHolding(s) in Company
22nd May 20248:30 amRNSDirector/PDMR Shareholding
21st May 20249:30 amRNSHolding(s) in Company
21st May 20247:00 amRNSPre-Close Trading Update
9th May 20247:00 amRNSBlock Listing Six Monthly Return
7th May 202410:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.